News
- Author:
- Neil Osterweil
Publish date: November 17, 2022
Participants who dieted and exercised in a community-based randomized trial had reductions in knee pain at 18 months; controls also improved somewh...
News
- Author:
- Neil Osterweil
Publish date: November 16, 2022
The incidence of all-cause mortality was higher for patients with rheumatoid arthritis who started on opioids rather than NSAIDs for pain control.<...
News
- Author:
- Neil Osterweil
Publish date: November 15, 2022
In an open-label, randomized trial, one in five patients on colchicine had diarrhea, tipping the safety scales in favor of prednisone.
News
- Author:
- Neil Osterweil
Publish date: November 14, 2022
In addition to its superior results on the primary endpoint of 90-day survival, combination therapy was associated with significantly better respon...
News
- Author:
- Neil Osterweil
Publish date: November 14, 2022
Danish investigators studied how a government-mandated switch from one infliximab biosimilar to another affected patients with inflammatory arthrit...
News
- Author:
- Neil Osterweil
Publish date: November 12, 2022
The guideline, based on data from a systematic review and meta-analysis and on consensus from an international team of experts and patients, define...
News
- Author:
- Neil Osterweil
Publish date: November 8, 2022
“As countries progress toward eliminating hepatitis B and C, we really need to do more to expand political will and financing of national...
News
- Author:
- Neil Osterweil
Publish date: November 8, 2022
“I do think it could be one of the drugs that really improves outcomes for patients with NASH.”
News
- Author:
- Neil Osterweil
Publish date: October 31, 2022
Risk factors for NAFLD vary with age, but all patients experience similar progression of advanced disease once it develops.
News
- Author:
- Neil Osterweil
Publish date: October 28, 2022
Later risk for advanced adenomas, serrated polyps, or colorectal cancer was lower for patients with an initial high-quality colonoscopy.
News
- Author:
- Neil Osterweil
Publish date: October 28, 2022
A reduced-volume bowel prep formulation was safe and was associated with high rates of adequate or better cleansing in a large practice-based study...
News
- Author:
- Neil Osterweil
Publish date: October 25, 2022
Genetic counseling and testing of patients under 50 with CRC have improved over the last decade, but about 20% of patients still don’t get referral...
News
- Author:
- Neil Osterweil
Publish date: October 25, 2022
Endoscopic ultrasound–guided radiofrequency ablation of tumors improved overall survival compared with standard of care.
News
- Author:
- Neil Osterweil
Publish date: October 20, 2022
Investigators seek balance between preserving mucus’s protective function and reducing oversecretion in inflammatory lung diseases.
News
- Author:
- Neil Osterweil
Publish date: September 22, 2022
In its first randomized, phase 3 comparison trial, the first-in-class agent sotorasib held its own against the standard of care docetaxel.
